Skip to content
10-K

Annual Report

Alto Neuroscience, Inc. ANRO

0001999480-25-000025

← back to feed
Filed
Mar 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 17, 2025 27.07M sh
Shares Diluted FY 2024 · Dec 31, 2023 3.73M sh
Capex FY 2024 · Dec 31, 2023 $470K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$33.45M
Long Term Debt FY 2024 · Dec 31, 2023 $9.86M
Cash And Equivalents FY 2024 · Dec 31, 2023 $82.55M
Current Liabilities FY 2024 · Dec 31, 2023 $5.61M
Total Liabilities FY 2024 · Dec 31, 2023 $16.82M
Current Assets FY 2024 · Dec 31, 2023 $85.39M
Total Assets FY 2024 · Dec 31, 2023 $86.63M
Eps Diluted FY 2024 · Dec 31, 2023 −$9.73
Eps Basic FY 2024 · Dec 31, 2023 −$9.73
Sga Expense FY 2024 · Dec 31, 2023 $7.52M
Rd Expense FY 2024 · Dec 31, 2023 $30.29M
Net Income FY 2024 · Dec 31, 2023 −$36.31M
Operating Income FY 2024 · Dec 31, 2023 −$37.81M
Stockholders Equity FY 2024 · Dec 31, 2022 −$38.41M